Drug combo extends pancreatic cancer patient survival
Wednesday, January 23, 2013 - 09:00
in Health & Medicine
A multi-center Phase III clinical trial demonstrates that Abraxane (nab-paclitaxel) plus gemcitabine is the first combination of cancer drugs to [...]